期刊文献+

叶酸调控H型高血压Hcy水平及心血管事件发生的临床观察 被引量:9

The clinical observation of folic acid on plasma homocysteine and cardiovascular events for patients with hyperhomocysteinima-related hypertention
暂未订购
导出
摘要 目的 研究观察叶酸调控H型高血压患者同型半胱氨酸(Hcy)水平和心血管事件发生概率的影响.方法 选择我院门诊治疗的134例H型高血压患者,均采用常规健康教育及降压治疗,同时加用叶酸调控治疗.所有患者均随访12个月,观察治疗前后患者血清Hcy水平变化及患者心血管事件发生情况.结果 患者治疗后Hcy水平明显下降,与治疗前比较差异有统计学意义.随访12个月,无心血管事件发生,发生率为0%,治疗前、后比较差异无统计学意义(P>0.05).结论 对H型高血压患者在常规治疗基础上采用叶酸调控治疗可降低患者Hcy水平,从而减少心血管事件的发生率,提高患者生活质量. Objective To evaluate and observe the effect of folic acid on plasma homocysteine and cardiovascular events in patients with hyperhomocysteinima-related hypertention.Methods 134 patients with hyperhomocysteinima-related hypertention were given the routine treatment with antihypertensive drug,in addition to folic acid.All patients were observed three months.Results After folic acid administration treatment for 12 months,the level of homocysteine was significantly decreased compared with the beginning (P<0.01).There were none cardiovascular events in the three months in the patients (P>0.05).Conclusion The treatment of with folic acid can reduce the level of plasma homocysteine and decreases the rates of cardiovascular events in patients with hyperhomocysteinima-related hypertention.
出处 《中国心血管病研究》 CAS 2014年第4期373-374,共2页 Chinese Journal of Cardiovascular Research
关键词 叶酸 H型高血压 同型半胱氨酸 心血管事件 Folic acid Hyperhomocysteinima-related hypertention Homocysteine Cardiovascular events
  • 相关文献

参考文献4

二级参考文献29

  • 1边云飞,高吊清,高奋,肖传实.兔饮食所致高同型半胱氨酸血症血管内皮功能的实验研究[J].中国病理生理杂志,2005,21(2):339-341. 被引量:6
  • 2梁爱华,丁晓霜,李文,薛宝云,王金华,杨洪军.血瘀证与血栓形成病证结合动物模型的研究[J].中国中药杂志,2005,30(20):1613-1616. 被引量:46
  • 3梁爱华,于长安,李春英,薛宝云,王金华,黄璐琦.内毒素与角叉菜胶联合诱导的血栓形成模型的动物差异性比较[J].中国中药杂志,2006,31(1):57-61. 被引量:7
  • 4崔晓辉,黄新莉,羡晓辉,凌亦凌.脂多糖性休克大鼠血浆和主要器官中硫化氢含量的变化和意义[J].中国病理生理杂志,2007,23(4):780-784. 被引量:13
  • 5Stankovic S,Majkic S N.Genetic aspects of ischemic stroke: coagulation,homocysteine,and lipoprotein metabolism as potential risk factors[J].Crit Rev Clin Lab Sci,2010,47(2): 72-123.
  • 6Graham I M,Daly L E,Refsum H M,et al .Plasma homocysteine as a risk factor for vascular disease[J].JAMA, 1997,277(22):1775-1781.
  • 7Sacco R L, Adams R, Albers G, et al.Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack:a statement for healthcare professionals from the American heart association/American stroke association council on stroke:co-sponsored by the council on cardiovascular radiology and intervention:the American academy of neurology affirms the value of this guideline[J].Stroke,2006, 37(2) :577-617.
  • 8Brosnan J T.Homocysteine and cardiovascular disease:interactions between nutrition,genetics and lifestyle[J].Can J Appl Physiol, 2004,29 ( 6 ) :773-780.
  • 9Salemi G,Gueli M C,D'Amelio M,et al.Blood levels of homocysteine,cysteine,glutathione,folie acid,and vitamin B12 in the acute phase of atherothrombotic stroke[J].Neu rol Sci, 2009,30 (3) :768-774.
  • 10Buccianti G,Baragetti I,Bamonti F,et al.Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease[J].Nephrol, 2004, 17 (3) :405-410.

共引文献116

同被引文献105

  • 1霍勇,徐希平.依靠我国循证医学证据,更加安全有效预防脑卒中——H型高血压防治的现状和展望[J].中国医学前沿杂志(电子版),2011,3(3):4-9. 被引量:30
  • 2康文娥.动态血压负荷对高血压病的评价作用[J].临床和实验医学杂志,2007,6(5):136-137. 被引量:6
  • 3中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华心血管病杂志,2011,390:579-616.
  • 4陈灏珠,林果为,王吉耀.实用内科学[M].第14版.北京:人民卫生出版社,2013,2019-2024.
  • 5李建平,霍勇,刘平,秦献辉,关德明,葛均波,胡健,王燕妮,张馥敏,毛广运,徐希平.马来酸依那普利叶酸片降压、降同型半胱氨酸的疗效和安全性[J].北京大学学报(医学版),2007,39(6):614-618. 被引量:394
  • 6Naureen A, Munazza B, Shaheen R, et al. Serum homocysteine as a risk factor for coronary heart disease. J Ayub Med Coll Ab- bottabad, 2012,24 : 59-62.
  • 7Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the primary prevention of stroke: a statement for healthcare pro- fessionals from the American Heart Association/American Stroke Association. Stroke, 2014,45 : 3754-3832.
  • 8Wald DS, Wald N J, Morris JK, et al. Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of incon- clusive trial evidence. BMJ, 2006,333 : 1114-1117.
  • 9Nazef K, Khelil M, Chelouti H, et al. Hyperhomocysteinemia is a risk factor for Alzheimer's disease in an Algerian population. Arch Med Res,2014,45:247-250.
  • 10Sato Y, Ouchi K, Funase Y, et al. Relationship between met- formin use, vitamin BI2 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes. Endocr J, 2013,60:1275-1280.

引证文献9

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部